CTLA4 and multiminicore myopathy: In patients with MMD, CTLA-4 expression was upregulated in CD4+ T cells but downregulated in CD8+ T cells, suggesting that CTLA-4 may serve to limit CD4+ T-cell activation and thereby mitigate pro-inflammatory cytokine release.